JAZZ — JAZZ PHARMACEUTICALS PLC

Ownership history in SUPERSTRING CAPITAL MANAGEMENT LP  ·  2 quarters on record

This page tracks every 13F SEC filing in which SUPERSTRING CAPITAL MANAGEMENT LP reported a position in JAZZ PHARMACEUTICALS PLC (JAZZ). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
5.54% (2025 Q2)
Avg. % of fund
5.43%
First filed
2025 Q2
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 40,893 -3,214 -7.3% 5.31% $5.4M $131.80
2025 Q2 INITIATED 44,107 — — 5.54% $4.7M $106.12
% of Fund (quarterly)    JAZZ price (monthly, adj. close)

Other funds also holding JAZZ

As of 2025 Q4 — sorted by position size

EcoR1 Capital, LLC 3Y 7Y 13.16% Krensavage Asset Management, LLC 3Y 7Y 10.08% Saturn V Capital Management LP 3Y 7.74% Sofinnova Investments, Inc. 3Y 7Y 7.04% Polaris Capital Management, LLC 3Y 7Y 6.1% Iron Triangle Partners LP 3Y 5.68% GMT CAPITAL CORP 3Y 7Y 5.66% GOLDENTREE ASSET MANAGEMENT LP 3Y 7Y 3.87% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 3.35% Resolute Capital Asset Partners LLC 3Y 3.29%
← Back to SUPERSTRING CAPITAL MANAGEMENT LP Holdings